Robotic aortic valve replacement in the Middle East: reproducibility into practice with evolving complexity.

Area of Science:

• Cardiac Surgery
• Minimally Invasive Procedures
• Robotic Surgery

Background:

• Robotic aortic valve replacement (RAVR) is increasingly adopted.
• Limited follow-up data exist for RAVR outcomes.
• This study assesses short- and mid-term clinical results of RAVR.

Purpose of the Study:

• To evaluate the clinical outcomes of patients undergoing robotic aortic valve replacement.
• To assess mortality, survival rates, and hospital complications post-RAVR.
• To analyze echocardiographic parameters at follow-up after RAVR.

Main Methods:

• Retrospective analysis of 15 patients who underwent RAVR between 2022 and 2024.
• Primary outcomes: mortality and survival.
• Secondary outcomes: hospital complications and echocardiographic data.

Main Results:

• No mortality reported in the median 24-month follow-up period.
• Patients were predominantly in New York Heart Association (NYHA) class I.
• Significant reduction in left ventricular end-diastolic diameter (LVEDD) observed post-RAVR.

Conclusions:

• RAVR demonstrates favorable short- and mid-term clinical outcomes.
• The procedure shows potential advantages due to its minimally invasive nature.
• RAVR may be a viable alternative to traditional and transcatheter valve procedures.